Nicholas J. Sarlis
Chief Tech/Sci/R&D Officer at Sellas Life Sciences Group Ltd.
Nicholas J. Sarlis active positions
| Companies | Position | Start | End |
|---|---|---|---|
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Nicholas J. Sarlis
Former positions of Nicholas J. Sarlis
| Companies | Position | Start | End |
|---|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Director/Board Member | 2017-12-28 | - |
| Chief Tech/Sci/R&D Officer | 2017-12-28 | 2020-02-29 | |
| INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 2010-08-31 | 2016-04-30 |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | 2001-12-31 | 2005-12-31 |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
Training of Nicholas J. Sarlis
| University of London | Doctorate Degree |
| National & Kapodistrian University of Athens | Doctorate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 2 |
| Greece | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Private companies | 2 |
|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Nicholas J. Sarlis
- Experience
